ScreenerHero
DIADiagnostyka S.A.
GPW · PL · Healthcare · Diagnostics & Research · diag.pl
166.40PLN+0.85%Mkt Cap: 1.41B $P/E: 21.32

Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap1.41B $
Enterprise Value1.69B $
Revenue (TTM)635.92M $
Gross Profit482.57M $
Net Income (TTM)63.72M $
Revenue/Share18.84 USD
Last Price166.40 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.6K
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLDGNST00012
Valuation
P/E (Trailing)21.32
P/E (Forward)16.68
PEG—
EV/EBITDA11.01
EV/Revenue2.65
P/S2.23
P/B9.27
EPS (TTM)7.74
EPS (Forward)—
52W Range
146.4027% of range219.90
52W High219.90 PLN
52W Low146.40 PLN
Profitability
Gross Margin79.05%
Oper. Margin18.06%
EBITDA Margin24.09%
Profit Margin10.44%
ROE47.62%
ROA12.16%
Growth
Revenue Growth14.60%
Earnings Growth13.30%
Cash Flow & Leverage
Operating CF139.74M $
CapEx (TTM)51.86M $
FCF Margin10.61%
FCF Yield4.79%
Net Debt270.83M $
Net Debt/EBITDA1.77
Balance Sheet
Debt/Equity2.05
Current Ratio0.80
Quick Ratio0.68
Book Value/Sh17.91 PLN
Cash/Share1.081 PLN
Dividends
Fwd Div Rate4.400 PLN
Trail. Div Rate4.400 PLN
Div. Yield2.65%
5Y Avg Yield—
Payout Ratio42.76%
Ex-Div DateJun 1, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)197.45 PLN
Upside (mean)+18.7%
Target Range176.00 PLN – 215.00 PLN
PLN176.00+18.7% to meanPLN215.00
# Analysts6
Ownership
Shares Out.33.76M
Float16.40M
Insiders47.20%
Institutions17.02%
Technical
SMA 50172.15 (-3.3%)
SMA 200173.79 (-4.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)28.00K
Avg Vol (10d)27.86K
Technical Indicators
RSI (14)40.4
MACD-1.3191
MACD Signal-1.2741
MACD Hist.-0.0450
BB Upper171.15 PLN
BB Middle167.09 PLN
BB Lower163.02 PLN
BB Width4.86%
ATR (14)3.519 PLN
Vol Ratio (20d)0.82x